Ashley Magargee will be Genentech's new permanent CEO as of Jan. 1. This article was originally published in the San Francisco Business Times, an American City Business Journals affiliate publication ...

Genentech’s brief leadership interregnum is coming to an end as the company’s interim chief executive, Ashley Magargee, prepares to take a permanent place on the throne. Magargee, who was tapped to ...

NEW YORK, March 16 (Reuters) - Roche's Genentech unit's Chief ‌Executive Ashley Magargee said ‌on Monday that the company's Xofluza flu drug will be on the government's TrumpRx.gov website when the ...

NEW YORK, March 16 (Reuters) - Roche (ROG.SW)'s Ashley Magargee, chief executive ‌of its Genentech unit, said ‌on Monday the company is striving to build a portfolio of obesity medicines that are both ...

Ashley Magargee will be Genentech's new permanent CEO as of Jan. 1. The list also includes Sandra Horning, who was Genentech's chief medical officer and served the dual role of CMO and global head of ...

FILE PHOTO: The logo of Swiss pharmaceutical company Roche is pictured on the company's headquarters in Basel February 4, 2009. REUTERS/Christian Hartmann/File Photo NEW YORK, March 16 (Reuters) - ...